Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;5(11):3111-3120.
doi: 10.1002/cam4.932. Epub 2016 Oct 17.

Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma

Hitomi Takada  1   2 , Kaoru Tsuchiya  1   3 , Yutaka Yasui  1 , Natsuko Nakakuki  1   2 , Nobuharu Tamaki  1 , Shoko Suzuki  1 , Hiroyuki Nakanishi  1 , Jun Itakura  1 , Yuka Takahashi  1 , Masayuki Kurosaki  1 , Yasuhiro Asahina  4 , Nobuyuki Enomoto  2 , Namiki Izumi  1
Affiliations

Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma

Hitomi Takada et al. Cancer Med. 2016 Nov.

Abstract

Radiofrequency ablation (RFA) is considered the most effective treatment for early-stage hepatocellular carcinoma (HCC) patients unsuitable for resection. However, poor outcome after RFA has occasionally been reported worldwide. To predict such an outcome, we investigated imaging findings using contrast-enhanced ultrasonography (CEUS) with Sonazoid and serum tumor markers before RFA. This study included 176 early-stage HCC patients who had initially achieved successful RFA. Patients were examined using CEUS; their levels of alpha-fetoprotein (AFP), Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3), and des-gamma-carboxy prothrombin before RFA were measured. Sonazoid provided parenchyma-specific contrast imaging and facilitated tumor vascular architecture imaging through maximum intensity projection (MIP). Kaplan-Meier analysis examined cumulative rates of local tumor progression, intrasubsegmental recurrence, and survival; factors associated with these were determined with Cox proportional hazards analysis. Local tumor progression (n = 15), intrasubsegmental recurrence (n = 46), and death (n = 18) were observed. Irregular pattern in MIP classification and serum AFP-L3 level (>10%) before RFA were identified as independent risk factors for local tumor progression and intrasubsegmental recurrence. These two factors were independently associated with poor survival after RFA (irregular pattern in MIP: hazard ratio, (HR) = 8.26; 95% confidence interval, (CI) = 2.24-30.3; P = 0.002 and AFP-L3 > 10%: HR = 2.94; 95% CI = 1.09-7.94; P = 0.033). Irregular MIP pattern by CEUS and high level of serum AFP-L3 were independent risk factors for poor outcome after successful RFA. The Patients with these findings should be considered as special high-risk group in early-stage HCC.

Keywords: Alpha-fetoprotein; contrast-enhanced ultrasonography; hepatocellular carcinoma; intrasubsegmental recurrence; poor survival; radiofrequency ablation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of case identification process. HCC; hepatocellular carcinoma, RFA;radiofrequency ablation, CEUS;contrast‐enhanced ultrasonography.
Figure 2
Figure 2
Images of MIP classification and Kupffer imaging. (A) Irregular pattern in MIP classification. (B) Vascular pattern in MIP classification. (C) Fine pattern in MIP classification. (D) Hypoechoic pattern in the Kupffer imaging in CEUS with Sonazoid. (E) Isoechoic pattern in the Kupffer imaging in CEUS with Sonazoid. MIP, maximum intensity projection; CEUS, contrast‐enhanced ultrasonography.
Figure 3
Figure 3
Kaplan–Meier plots for local tumor progression after successful RFA, according to an echoic pattern in the Kupffer phase in CEUS before treatment.
See this image and copyright information in PMC

References

    1. Torre, L. A. , Bray F., Siegel R. L., Ferlay J., Lortet‐Tieulent J., and Jemal A.. 2012. Global cancer statistics. CA Cancer J. Clin. 2015. 65:87–108. - PubMed
    1. Tateishi, R. , Shiina S., Teratani T., Obi S., Sato S., Koike Y., et al. 2005. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209. - PubMed
    1. Shiina, S. , Tateishi R., Arano T., Uchino K., Enooku K., Nakagawa H., et al. 2012. Radiofrequency ablation for hepatocellular carcinoma: 10‐year outcome and prognostic factors. Am. J. Gastroenterol. 107:569–577. - PMC - PubMed
    1. Lee, D. H. , Lee J. M., Lee J. Y., Kim S. H., Yoon J. H., Kim Y. J., et al. 2014. Radiofrequency ablation of hepatocellular carcinoma as first‐line treatment: long‐term results and prognostic factors in 162 patients with cirrhosis. Radiology 270:900–909. - PubMed
    1. Shin, S. , Lee J. M., Kim K. W., Joo I., Han J. K., B. I. Choi , et al. 2014. Postablation assessment using follow‐up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma. AJR Am. J. Roentgenol. 203:70–77. - PubMed

MeSH terms